步科股份(688160) - 2023 Q4 - 年度财报

Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.2 billion CNY for the fiscal year, representing a 15% year-over-year growth[18]. - The company's operating revenue for 2023 was CNY 506,480,267.79, a decrease of 6.09% compared to CNY 539,306,528.56 in 2022[26]. - Net profit attributable to shareholders was CNY 60,683,399.68, representing a decline of 33.36% from CNY 91,055,542.86 in the previous year[26]. - The basic earnings per share decreased by 33.33% to CNY 0.72 from CNY 1.08 in 2022[27]. - The diluted earnings per share also fell to CNY 0.72, down 33.33% from CNY 1.08 in the previous year[28]. - The gross profit margin for 2023 was 38.07%, an increase from 37.92% in 2022[99]. - The company achieved operating revenue of 506.48 million yuan, a decrease of 6.09% year-on-year[35]. - The company reported a total of CNY 6,866,819.01 in non-recurring gains for 2023, compared to CNY 4,307,899.47 in 2022[31]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of 3 RMB per 10 shares, totaling 25.2 million RMB (before tax) based on a total share capital of 84 million shares as of December 31, 2023[6]. - The company has a cash dividend policy that mandates a minimum of 10% of the distributable profit to be distributed annually, with a cumulative minimum of 30% over three years[185]. - The company declared a cash dividend of 3.00 RMB per 10 shares, totaling 25,200,000.00 RMB, which represents 41.53% of the net profit attributable to ordinary shareholders in the consolidated financial statements[190]. Research and Development - The company is investing in AI technology, with a budget allocation of 100 million CNY for research and development[18]. - Research and development expenses accounted for 11.38% of operating revenue, up from 8.63% in 2022, indicating increased investment in innovation[28]. - The company holds a total of 117 patents, including 15 invention patents, with 22 new patent applications during the reporting period[42]. - The company’s R&D investment totaled approximately ¥57.65 million, representing a 23.89% increase from the previous year's ¥46.53 million[78]. - The company has established R&D centers in multiple cities including Shanghai, Shenzhen, Chengdu, and Changzhou, enhancing its technological and product innovation capabilities[90]. Market Expansion and Strategy - The company provided guidance for the next fiscal year, projecting a revenue growth of 20% to 1.44 billion CNY[18]. - Market expansion plans include entering two new international markets, targeting a 10% increase in overall market share[18]. - The company is exploring potential acquisitions to enhance its technology portfolio, with a budget of 300 million CNY set aside for this purpose[18]. - The company is focusing on expanding its market presence in sectors such as industrial automation, medical imaging, and renewable energy[82]. - The company plans to enhance its overseas market presence by establishing local service centers and recruiting local sales teams[140]. Corporate Governance - The board of directors has confirmed the authenticity, accuracy, and completeness of the annual report[5]. - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[8]. - The company has not violated decision-making procedures for providing guarantees[9]. - The company has established specialized committees under the board, including a strategic committee and an audit committee, to enhance governance and operational efficiency[149]. - The company is committed to improving its governance structure in accordance with the Company Law and Securities Law, enhancing decision-making processes[144]. Operational Efficiency and Technology - A new digital factory initiative is being implemented, aimed at improving production efficiency by 30%[18]. - The company has adopted IoT solutions in its operations, which are expected to reduce operational costs by 15%[18]. - The company has developed a digital factory solution that integrates digital technology with automation products, enabling data connectivity for machine and factory management[70]. - The company has implemented a scientific human resource management system to enhance organizational vitality and attract high-end professional talent[47]. - The company has made significant advancements in core technologies, focusing on industrial automation, robotics, and factory digitization, with multiple intellectual property rights acquired[67]. Risks and Challenges - The company has outlined potential risks in its annual report, which investors should consider[5]. - The company faces risks related to insufficient R&D investment and potential loss of key technical personnel, which could impact its competitive advantage[95]. - The company faced risks related to reliance on imported raw materials, with a significant portion of procurement from overseas suppliers[96]. Employee and Management - The total number of employees in the parent company and major subsidiaries is 688, with 294 in production, 159 in sales, and 170 in technical roles[180]. - The total remuneration for all directors, supervisors, and senior management personnel at the end of the reporting period amounted to RMB 640.34 million[167]. - The company has a labor outsourcing total of 74,611.50 hours, with total payments amounting to 1,919,354.03 CNY[184]. - The company’s training program focuses on enhancing employee skills and overall quality through differentiated learning objectives and courses[183]. Future Outlook - Future guidance indicates a projected revenue growth of approximately 10% year-over-year, driven by new product launches and market expansion efforts[157]. - The company plans to continue expanding its marketing team to support long-term growth, resulting in increased sales expenses[107]. - The company is committed to research and development, with significant investments planned for innovative technologies in the next fiscal year[157].